GMXPX
Price
$25.03
Change
-$0.03 (-0.12%)
Updated
Sep 5 closing price
Net Assets
551.5M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

GMXPX vs VVIAX

Header iconGMXPX vs VVIAX Comparison
Open Charts GMXPX vs VVIAXBanner chart's image
Goldman Sachs Large Cp Val Insghts P
Price$25.03
Change-$0.03 (-0.12%)
VolumeN/A
Net Assets551.5M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
GMXPX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GMXPX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMXPX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. GMXPX (551M). VVIAX pays higher dividends than GMXPX: VVIAX (2.10) vs GMXPX (1.17). GMXPX was incepted earlier than VVIAX: GMXPX (7 years) vs VVIAX (25 years). GMXPX (0.65) is less costly to investors than VVIAX (0.05). GMXPX is a more actively managed with annual turnover of: 206.00 vs. VVIAX (9.00). GMXPX has a lower initial minimum investment than VVIAX: GMXPX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. GMXPX (-2.42). VVIAX return over 5 years is better than : 70.16 vs. GMXPX (33.83).
GMXPXVVIAXGMXPX / VVIAX
Total Expense Ratio0.550.051,100%
Annual Report Gross Expense Ratio0.650.051,300%
Fund Existence7 years25 years-
Gain YTD9.0327.850115%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets551M203B0%
Annual Yield % from dividends1.172.1056%
Returns for 1 year-2.427.74-31%
Returns for 3 years24.1736.6166%
Returns for 5 years33.8370.1648%
Returns for 10 yearsN/A131.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity